Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System

NACompletedINTERVENTIONAL

Enrollment

304

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

September 30, 2017

Conditions

Diabetes Mellitus

Interventions

DEVICE

CGM

Glucose challenge during a clinic session to assess CGM performance compared to a laboratory reference measurement.

Trial Locations (9)

AMCR Institute, Escondido

Stanford, Palo Alto

Sansum, Santa Barbara

Diablo, Walnut Creek

Barbara Davis Center, Aurora

Atlanta Diabetes, Atlanta

Joslin Diabetes Center, Boston

Oregon Health Science University, Portland

Rainier, Seattle

All Listed Sponsors

lead

DexCom, Inc.

INDUSTRY

NCT02880267 - Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System | Biotech Hunter | Biotech Hunter